Vol 72, No 3 (2021)
Clinical vignette
Published online: 2021-03-04
Clinicopathological features of neonatal subcutaneous fat necrosis and its implications
12
, 12, 32, 4, 52, 52, 52, 32
, 12, 32, 4, 52, 52, 52, 32
Abstract
Not required for Clinical Vignette
Keywords: subcutaneous fat necrosisnewbornhypercalcaemia
References
- Stefanko NS, Drolet BA. Subcutaneous fat necrosis of the newborn and associated hypercalcemia: A systematic review of the literature. Pediatr Dermatol. 2019; 36(1): 24–30.
- Kannenberg SMH, Jordaan HF, Visser WI, et al. Report of 2 Novel Presentations of Subcutaneous Fat Necrosis of the Newborn. Dermatopathology (Basel). 2019; 6(2): 147–152.
- Muzy G, Mayor SA, Lellis RF. Subcutaneous fat necrosis of the newborn: clinical and histopathological correlation. An Bras Dermatol. 2018; 93(3): 412–414.
- Farooque A, Moss C, Zehnder D, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol. 2009; 160(2): 423–425.
- Sharata H, Postellon DC, Hashimoto K. Subcutaneous fat necrosis, hypercalcemia, and prostaglandin E. Pediatr Dermatol. 1995; 12(1): 43–47.
